This bill would cancel the FDA’s January 2023 rule changes for mifepristone. It would also stop federal health officials from bringing back the same, or nearly the same, rules later.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes. is a House bill in committee. The latest recorded action: Referred to the House Committee on Energy and Commerce.
Latest action on H.R. 679: Referred to the House Committee on Energy and Commerce.
Who this affects: This bill mainly affects people who use or provide mifepristone, along with the federal officials who regulate it. Patients could face different steps to get the drug. Doctors and pharmacies could face different rules for prescribing or dispensing it. The FDA and the Department of Health and Human Services would have less freedom to return to the January 2023 policy.
Why this matters: This bill matters because it could change how patients get mifepristone and how health care providers handle it. The bill deals with safety rules for one abortion drug, not abortion law as a whole. It could also shift power from federal health agencies to Congress by blocking the agencies from returning to the January 2023 approach.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Officially: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
This bill would cancel the FDA’s January 2023 rule changes for mifepristone. It would also stop federal health officials from bringing back the same, or nearly the same, rules later.
Use this page to support, oppose, or ask Congress to amend HR679. Modern Action explains To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes. in plain English, helps identify the right senators or representative, and drafts a bill-specific message you can edit and send.
Where it stands
Sitting in House Committee
No vote scheduled. Constituent contact is what moves bills out of committee.
↓ Why your message matters here
This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
The debate
Where this bill is in the process
Introduced
Introduced in House
House Committee
Under House committee consideration
Latest: Referred to the House Committee on Energy and Commerce. (1/23/2025)
House Floor Vote
Voted on by House
Passed House
Approved by House
Senate Review
Sent to Senate for consideration
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail
Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can edit and send.
Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your House representative when that is the most relevant target for this bill.
The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you can edit the message before sending.
This page gives you an opportunity to support, oppose, or ask for changes to To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes., then contact the elected officials who can act. Modern Action drafts the message from your position and the reasons you select.
Modern Action keeps the action tied to the bill itself: what it would do, where it is in the process (committee), which office can still act, and what ask belongs in the message.
You are not starting from a blank form. Modern Action drafts the message around HR679, your stance, and the reasons you choose, then lets you edit and send when ready.
